StockData
Filana Therapeutics, Inc. logo

Filana Therapeutics, Inc. (FLNA) stock

FLNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$0.64+0.08 (+14.52%)

Close on Nov 20, 2026Market cap $30.98MP/E –Yield –

Filana Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Filana Therapeutics's pe ratio was 4.0× on Jan 30, 2015.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2015Jan 30, 20154.0×−0.1
2014Dec 31, 20144.1×–

More Filana Therapeutics figures

See a number that looks wrong?